 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Corvus Pharmaceuticals Inc. (CRVS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-12 Purchase | 2019-11-14 4:14 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 15,008 | $3 | $45,029 | 1,178,515 (Indirect) | View |
| 2019-08-06 Purchase | 2019-08-08 5:00 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner | 142,656 | $3.51 | $500,723 | 6,767,584 (Indirect) | View |
| 2019-08-06 Purchase | 2019-08-08 4:59 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director, 10% Owner | 142,656 | $3.51 | $500,723 | 6,767,584 (Indirect) | View |
| 2019-08-06 Purchase | 2019-08-08 4:07 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 7,500 | $3.563 | $26,725 | 1,163,507 (Indirect) | View |
| 2019-07-23 Sale | 2019-07-25 7:21 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,492,956 | $4.071 | $6,077,845 | 4,380,800 (Direct) | View |
| 2019-06-27 Purchase | 2019-07-01 6:16 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner | 657,344 | $3.718 | $2,444,065 | 6,624,928 (Indirect) | View |
| 2019-06-27 Purchase | 2019-07-01 6:15 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director, 10% Owner | 657,344 | $3.718 | $2,444,065 | 6,624,928 (Indirect) | View |
| 2019-06-13 Purchase | 2019-06-17 4:08 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 12,000 | $3.406 | $40,874 | 1,156,007 (Indirect) | View |
| 2019-06-07 Purchase | 2019-06-11 4:55 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 15,212 | $3.487 | $53,039 | 1,144,007 (Indirect) | View |
| 2019-06-06 Purchase | 2019-06-10 4:12 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 25,500 | $3.489 | $88,980 | 149,206 (Indirect) | View |
| 2018-12-27 Purchase | 2018-12-31 4:16 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 20,000 | $3.294 | $65,884 | 1,128,795 (Indirect) | View |
| 2018-12-21 Purchase | 2018-12-27 4:08 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 24,700 | $4.146 | $102,409 | 149,206 (Indirect) | View |
| 2018-12-20 Purchase | 2018-12-26 4:05 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 10,000 | $4.395 | $43,950 | 1,108,795 (Indirect) | View |
| 2018-12-06 Purchase | 2018-12-10 4:05 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 5,000 | $5.987 | $29,934 | 1,118,795 (Indirect) | View |
| 2018-12-04 Purchase | 2018-12-06 4:06 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 1,502 | $5.95 | $8,937 | 1,113,795 (Indirect) | View |
| 2018-03-12 Purchase | 2018-03-14 2:05 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner | 588,235 | $8.5 | $4,999,998 | 5,967,584 (Indirect) | View |
| 2018-03-12 Purchase | 2018-03-14 1:58 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director, 10% Owner | 588,235 | $8.5 | $4,999,998 | 5,967,584 (Indirect) | View |
| 2018-03-12 Purchase | 2018-03-13 5:12 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,176,470 | $8.5 | $9,999,995 | 4,420,516 (Direct) | View |
| 2018-03-12 Purchase | 2018-03-13 4:07 pm | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner | 588,235 | $8.5 | $4,999,998 | 2,687,381 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-20 Option Award | 2019-06-24 4:09 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $3.61 | 3,275,616 (Indirect) | View |
| 2019-06-20 Option Award | 2019-06-24 4:07 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director | 15,000 | $3.61 | 15,000 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:06 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $3.61 | 15,000 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:05 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner | 15,000 | $3.61 | 3,275,616 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:05 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda S Director | 15,000 | $3.61 | 15,000 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:05 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner | 15,000 | $3.61 | 5,967,584 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:05 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $3.61 | 15,000 (Direct) | View |
| 2019-01-28 Option Award | 2019-01-30 4:08 pm | N/A 2029-01-28 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda S Director | 30,000 | $3.88 | 30,000 (Direct) | View |
| 2019-01-28 Option Award | 2019-01-30 4:07 pm | N/A 2029-01-28 | Corvus Pharmaceuticals Inc. | CRVS | Mobasher Mehrdad Chief Medical Officer | 210,000 | $3.88 | 210,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-14 4:09 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 100,000 | $5.94 | 113,773 (Direct) | View |
| 2018-12-12 Gift | 2018-12-14 4:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 10,000 | $0 | 1,108,795 (Indirect) | View |
| 2018-12-12 Gift | 2018-12-14 4:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 10,000 | $0 | 1,108,795 (Indirect) | View |
| 2018-12-12 Option Award | 2018-12-14 4:07 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 250,000 | $5.94 | 1,108,795 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-14 4:06 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Buggy Joseph J VP | 100,000 | $5.94 | 266,310 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-14 4:06 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 100,000 | $5.94 | 149,206 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-14 4:05 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Hunt Daniel W. SVP Chief Business Officer | 50,000 | $5.94 | 50,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-14 4:05 pm | N/A 2028-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Verner Erik J. VP | 50,000 | $5.94 | 63,773 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:15 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $12.5 | 3,275,616 (Indirect) | View |
| 2018-06-21 Option Award | 2018-06-25 4:06 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner | 15,000 | $12.5 | 5,967,584 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:05 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $12.5 | 15,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:05 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner | 15,000 | $12.5 | 3,275,616 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:05 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $12.5 | 15,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:05 pm | N/A 2028-06-21 | Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director | 15,000 | $12.5 | 15,000 (Direct) | View |